ATE271614T1 - Quinone-derivate zur verbesserung der zellulare bioenergie - Google Patents
Quinone-derivate zur verbesserung der zellulare bioenergieInfo
- Publication number
- ATE271614T1 ATE271614T1 AT93909698T AT93909698T ATE271614T1 AT E271614 T1 ATE271614 T1 AT E271614T1 AT 93909698 T AT93909698 T AT 93909698T AT 93909698 T AT93909698 T AT 93909698T AT E271614 T1 ATE271614 T1 AT E271614T1
- Authority
- AT
- Austria
- Prior art keywords
- pct
- animal
- present
- sec
- therapeutic compositions
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
- G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C50/00—Quinones
- C07C50/02—Quinones with monocyclic quinoid structure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C50/00—Quinones
- C07C50/02—Quinones with monocyclic quinoid structure
- C07C50/06—Quinones with monocyclic quinoid structure with unsaturation outside the quinoid structure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C50/00—Quinones
- C07C50/26—Quinones containing groups having oxygen atoms singly bound to carbon atoms
- C07C50/28—Quinones containing groups having oxygen atoms singly bound to carbon atoms with monocyclic quinoid structure
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPL264292 | 1992-05-28 | ||
AUPL264192 | 1992-05-28 | ||
PCT/AU1993/000251 WO1993024650A1 (en) | 1992-05-28 | 1993-05-28 | Therapeutic compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE271614T1 true ATE271614T1 (de) | 2004-08-15 |
Family
ID=25644259
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT93909698T ATE271614T1 (de) | 1992-05-28 | 1993-05-28 | Quinone-derivate zur verbesserung der zellulare bioenergie |
Country Status (10)
Country | Link |
---|---|
US (1) | US5981601A (de) |
EP (1) | EP0643775B1 (de) |
JP (1) | JP3859699B2 (de) |
AT (1) | ATE271614T1 (de) |
AU (1) | AU666372B2 (de) |
DE (1) | DE69333575T2 (de) |
DK (1) | DK0643775T3 (de) |
ES (1) | ES2224098T3 (de) |
PT (1) | PT643775E (de) |
WO (1) | WO1993024650A1 (de) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9626177D0 (en) * | 1996-12-17 | 1997-02-05 | Univ Aberdeen | Channel mediating substrates |
ATE462004T1 (de) * | 1997-09-16 | 2010-04-15 | Centocor Inc | Methoden zur kompletten chemischen synthese und zusammensetzung von genen und genomen |
US6670127B2 (en) | 1997-09-16 | 2003-12-30 | Egea Biosciences, Inc. | Method for assembly of a polynucleotide encoding a target polypeptide |
US7915233B1 (en) | 1998-08-31 | 2011-03-29 | Wellstat Therapeutics Corporation | Compositions and methods for treatment of mitochondrial diseases |
US7807654B2 (en) * | 1998-08-31 | 2010-10-05 | Wellstat Therapeutics Corporation | Compositions and methods for treatment of mitochondrial diseases |
US6472378B2 (en) * | 1998-08-31 | 2002-10-29 | Pro-Neuron, Inc. | Compositions and methods for treatment of mitochondrial diseases |
US20050019268A1 (en) * | 1999-02-11 | 2005-01-27 | Mse Pharmazeutika Gmbh | Spray containing ubiquinone Qn |
DE60037578T2 (de) | 1999-02-23 | 2009-01-08 | The Regents Of The University Of California, Oakland | Verwendung von triacetyluridin zur behandlung von mitochondrialen erkrankungen |
US20040224920A1 (en) * | 1999-02-23 | 2004-11-11 | The Regents Of The University Of California | Methods of treatment of mitochondrial disorders |
AUPR177300A0 (en) * | 2000-11-29 | 2000-12-21 | Centre For Molecular Biology And Medicine | Therapeutic methods |
WO2002081490A2 (en) * | 2001-01-19 | 2002-10-17 | Egea Biosciences, Inc. | Computer-directed assembly of a polynucleotide encoding a target polypeptide |
US7629329B2 (en) * | 2001-06-04 | 2009-12-08 | Tsi Health Sciences, Inc. | Method for increasing muscle mass and strength through administration of adenosine triphosphate |
WO2003002147A1 (fr) * | 2001-06-28 | 2003-01-09 | Takeda Chemical Industries, Ltd. | Medicaments destines a la prevention/au traitement de troubles fonctionnels des organes et du dysfonctionnement des organes |
TW200304372A (en) * | 2002-03-20 | 2003-10-01 | Kanegafuchi Chemical Ind | Compositions for diabetes |
US20030182278A1 (en) * | 2002-03-25 | 2003-09-25 | Valk Jeffrey W. | Stateless cursor for information management system |
PT1594456E (pt) * | 2003-01-20 | 2008-12-16 | Auriga Internat S A | Utilização de uma composição contendo óxido de vitamina k1 ou um seu derivado para tratamento e/ou prevenção de lesões dermatológicas em mamíferos |
DK2564843T3 (en) | 2005-06-01 | 2019-03-11 | Bioelectron Tech Corp | Redox-active therapeutics for the treatment of mitochondrial diseases and other conditions as well as modulation of energy biomarkers |
US7432305B2 (en) * | 2005-09-15 | 2008-10-07 | Edison Pharmaceuticals, Inc. | Tail variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers |
US9278085B2 (en) | 2006-02-22 | 2016-03-08 | Edison Pharmaceuticals, Inc. | Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers |
EP2262519A4 (de) * | 2008-03-05 | 2011-03-23 | Edison Pharmaceuticals Inc | Behandlung von gehör- und gleichgewichtsstörungen mit redoxaktiven therapeutika |
JP2012502064A (ja) | 2008-09-10 | 2012-01-26 | エジソン ファーマシューティカルズ, インコーポレイテッド | 酸化還元活性治療剤を用いての広汎性発達障害の処置 |
KR100977638B1 (ko) * | 2009-06-29 | 2010-08-24 | 서울대학교산학협력단 | 독성분이 있는 배출가스 혼합체에 생존하면서 온실가스를 흡수한 수생식물의 포식자를 이용하는 온실가스 제거 및 바이오 에너지 제조 방법 |
KR101636946B1 (ko) * | 2013-07-29 | 2016-07-06 | 한국생명공학연구원 | 오로트산을 포함하는 근력약화 관련 질환의 예방 또는 치료용 약학적 조성물 |
WO2017106803A1 (en) | 2015-12-17 | 2017-06-22 | Bioelectron Technology Corporation | Flouroalkyl, flouroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders |
WO2018218287A1 (en) * | 2017-05-29 | 2018-12-06 | Woodlinda Pty Ltd | Treatment and/or prevention of neuropathic symptoms associated with diabetes mellitus type ii |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3705239A (en) * | 1970-10-16 | 1972-12-05 | Roy B Gregory | Pain removing compositions and methods |
JPS5697223A (en) * | 1979-12-30 | 1981-08-05 | Takeda Chem Ind Ltd | Tissue metabolism activator |
CH655005A5 (it) * | 1983-02-16 | 1986-03-27 | Sigma Tau Ind Farmaceuti | Composizione farmaceutica ad azione metabolica ed energetica utilizzabile in terapia cardiaca e vascolare. |
JPS59163316A (ja) * | 1983-03-08 | 1984-09-14 | Eisai Co Ltd | けいれんの治療・予防剤 |
JPS60100517A (ja) * | 1983-11-08 | 1985-06-04 | Eisai Co Ltd | 放射線潰瘍治療剤および方法 |
IL78611A0 (en) * | 1986-04-23 | 1986-08-31 | Yeda Res & Dev | Production of polyprenoid and ubiquinone-type compounds |
US5227405A (en) * | 1987-03-31 | 1993-07-13 | Duke University | Superoxide dismutase mimic |
JPH01165522A (ja) * | 1987-12-23 | 1989-06-29 | M S C:Kk | 鼻及びのどの疾患の治療剤 |
WO1992003052A1 (en) * | 1990-08-23 | 1992-03-05 | Jariwalla Raxit J | Method for suppression of hiv replication by ascorbate for chronic and acute hiv infection |
FR2674753B1 (fr) * | 1991-04-02 | 1995-03-10 | Jean Berque | Nouvelles indications therapeutiques, en particulier pour le traitement du sida, d'un medicament deja existant et fabrique a partir d'une molecule denuee de contre-indications et d'effets indesirables. |
US5281628A (en) * | 1991-10-04 | 1994-01-25 | American Cyanamid Company | 9-amino-7-(substituted)-6-demethyl-6-deoxytetracyclines |
US5460819A (en) * | 1991-12-13 | 1995-10-24 | Children's Medical Center Corporation | Method for treating PQQ-responsive heavy metal toxicity |
JPH1165522A (ja) * | 1997-08-25 | 1999-03-09 | Mitsubishi Electric Corp | プラズマディスプレイパネルの駆動方法 |
-
1993
- 1993-05-28 ES ES93909698T patent/ES2224098T3/es not_active Expired - Lifetime
- 1993-05-28 DE DE69333575T patent/DE69333575T2/de not_active Expired - Lifetime
- 1993-05-28 JP JP50002894A patent/JP3859699B2/ja not_active Expired - Lifetime
- 1993-05-28 US US08/343,559 patent/US5981601A/en not_active Expired - Lifetime
- 1993-05-28 AT AT93909698T patent/ATE271614T1/de not_active IP Right Cessation
- 1993-05-28 PT PT93909698T patent/PT643775E/pt unknown
- 1993-05-28 WO PCT/AU1993/000251 patent/WO1993024650A1/en active IP Right Grant
- 1993-05-28 DK DK93909698T patent/DK0643775T3/da active
- 1993-05-28 AU AU40545/93A patent/AU666372B2/en not_active Ceased
- 1993-05-28 EP EP93909698A patent/EP0643775B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0643775A4 (de) | 1995-12-27 |
AU4054593A (en) | 1993-12-30 |
EP0643775A1 (de) | 1995-03-22 |
US5981601A (en) | 1999-11-09 |
WO1993024650A1 (en) | 1993-12-09 |
JPH08500091A (ja) | 1996-01-09 |
DK0643775T3 (da) | 2004-09-06 |
DE69333575T2 (de) | 2005-08-25 |
ES2224098T3 (es) | 2005-03-01 |
EP0643775B1 (de) | 2004-07-21 |
DE69333575D1 (de) | 2004-08-26 |
PT643775E (pt) | 2004-10-29 |
AU666372B2 (en) | 1996-02-08 |
JP3859699B2 (ja) | 2006-12-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE271614T1 (de) | Quinone-derivate zur verbesserung der zellulare bioenergie | |
KR19980700976A (de) | ||
ATE84414T1 (de) | Verwendung von gamma-linolensaeure und verwandten verbindungen zur herstellung eines arneimittels zur behandlung von komplikationen bei diabetes mellitus. | |
EA199800943A1 (ru) | Производные мочевины и их применение в качестве ингибиторов инозин-5`-монофосфат- дегидрогеназы | |
TR200000481T2 (tr) | N-Alkonoilfenilalenin türevleri. | |
ES8603455A1 (es) | Un metodo para preparar derivados de piperazina | |
NO954440L (no) | 2 pyridylmetylenpolyazamakrocyklo-fosfonsyrer, komplekser og derivater derav, for anvendelse som kontrastmidler | |
DE69735442D1 (de) | Antidiabetische mittel | |
DE69805983T2 (de) | Hustenhemmende, theobromine enthaltende zusammensetzungen | |
MX9307509A (es) | Metodo y preparacion farmaceutica para reducir la actividad de las celulas. | |
ATE84045T1 (de) | Hemmungsstoffe enkephalinase-b deren herstellung und deren pharmazeutische zusammensetzungen. | |
ATE39357T1 (de) | Derivate von griseolicsaeure und ihre verwendung. | |
KR950031085A (ko) | 표피증식 질환 치료용 의약 조성물 | |
ES8407321A1 (es) | "un procedimiento para preparar un compuesto organico de selenio" | |
GB1474424A (en) | Pharmaceutical composition for treating diabetic ketoacidosis | |
ATE551058T1 (de) | Zusammensetzungen enthaltend tempamine und deren verwendung zum schutz vor oxidativer schädigung | |
JPH07258024A (ja) | メラニン生成阻害剤 | |
TH29868A (th) | วิธีการและองค์ประกอบของสารสำหรับทำให้สีของผิวหนังจางลง |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 0643775 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |